Modernized Plant

 

Our global fatty acid production network has state-of-the-art manufacturing facilities in China and New Zealand. Including dedicated research and development laboratories and proprietary intelligent management platforms. Advanced technologies ensures controllable costs, reliable technology, stable quality, and scalable production capacity. 

Our vertically integrated supply chain has mature raw material procurement channels.. We operate several internationally certified production lines. These can provide fatty acid raw materials, multi-dimensional formula, soft capsules, microencapsulated powder, tablets, gel candy, etc. All products comply with major pharmacopoeia standards, including CP2025, USP2024-NF42, EP10.0-2019, JP18, and KP12. Our annual production capacity reaches 1500 metric tons of fatty acids, 5 billion soft capsules, 3 billion tablets, and 500 metric tons of microcapsule powder. Maxhealth is a trusted partner for leading global organizations.

Automatic Control System

Modularized Production Line

Automated Filling Line   

Capsule Packaging Line